[go: up one dir, main page]

PE20080347A1 - Solucion oftalmica de ciprofloxacina y dexametasona - Google Patents

Solucion oftalmica de ciprofloxacina y dexametasona

Info

Publication number
PE20080347A1
PE20080347A1 PE2007000833A PE2007000833A PE20080347A1 PE 20080347 A1 PE20080347 A1 PE 20080347A1 PE 2007000833 A PE2007000833 A PE 2007000833A PE 2007000833 A PE2007000833 A PE 2007000833A PE 20080347 A1 PE20080347 A1 PE 20080347A1
Authority
PE
Peru
Prior art keywords
dexametasone
cyprofloxacin
ophthalmic solution
approximately
sodium
Prior art date
Application number
PE2007000833A
Other languages
English (en)
Inventor
Hau Juan De Dios Quintana
Montano Jose Ruben Tornero
Duran Leopoldo Martin Baiza
Franco Norma Patricia Rodriguez
Jaime R Gonzalez
Original Assignee
Jimenez Bayardo Arturo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38845821&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080347(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jimenez Bayardo Arturo filed Critical Jimenez Bayardo Arturo
Publication of PE20080347A1 publication Critical patent/PE20080347A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA OFTALMICA EN SOLUCION PARA APLICACION TOPICA, QUE COMPRENDE: A) DEXAMETASONA MICRONIZADA APROXIMADAMENTE 0,1%; B) CLORHIDRATO DE CIPROFLOXACINO MONOHIDRATADO APROXIMADAMENTE AL 0,3%; C) CLORURO DE SODIO EN CANTIDAD SUFICIENTE PARA OBTENER 250-350mOsm/K; D) HIDROXIPROPILBETACICLODEXTRINAS AL 6%, SULFATO DE SODIO, EDETATO SODICO, CLORURO DE BENZALCONIO POLISORBATO 80 COMO SURFACTANTE NO IONICO. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE PADECIMIENTOS OCULARES CAUSADOS POR BACTERIAS Y HONGOS
PE2007000833A 2006-06-27 2007-06-27 Solucion oftalmica de ciprofloxacina y dexametasona PE20080347A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2006/000062 WO2008002117A1 (es) 2006-06-27 2006-06-27 Solución oftálmica de ciprofloxacina y dexametasona

Publications (1)

Publication Number Publication Date
PE20080347A1 true PE20080347A1 (es) 2008-04-11

Family

ID=38845821

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000833A PE20080347A1 (es) 2006-06-27 2007-06-27 Solucion oftalmica de ciprofloxacina y dexametasona

Country Status (3)

Country Link
CL (1) CL2007001894A1 (es)
PE (1) PE20080347A1 (es)
WO (1) WO2008002117A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107970244B (zh) * 2016-10-21 2020-07-14 武汉武药科技有限公司 一种含有环丙沙星和地塞米松的组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6740664B2 (en) * 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
CA2428189A1 (en) * 2000-11-15 2002-05-23 Mainde Chandrashekhar Pharmaceutival preparations comprising corticosteroids and antiinfective agents
WO2004069280A1 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent
CA2516429A1 (en) * 2003-02-21 2004-10-14 Sun Pharmaceutical Industries Limited Stable ophthalmic formulation containing an antibiotic and a corticosteroid

Also Published As

Publication number Publication date
WO2008002117A1 (es) 2008-01-03
CL2007001894A1 (es) 2008-01-04

Similar Documents

Publication Publication Date Title
ME01456B (me) Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola
BR112012008518A2 (pt) derivado heterocíclico, e, composição farmacêutica
PE20131324A1 (es) Formulacion subcutanea de anticuerpo anti-her2
PE20130009A1 (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana
PE20141676A1 (es) Composiciones de yodo-povidona estable
PE20141070A1 (es) Composiciones estables de povidona yodada con antiinflamatorios esteroideos o no esteroideos
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
PE20121498A1 (es) Composiciones oftalmicas no irritantes de povidona-yodo
BRPI0518301A2 (pt) inseticidas
IN2012DN02465A (es)
NO20084853L (no) Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni
AU2012243329A8 (en) 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
CL2008001839A1 (es) Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
CO6541569A2 (es) Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa
BR112013005438A2 (pt) "agente para o tratamento de olho ressecado caracterizado por combinar o agonista do receptor de p2y2 e ácido hialurônico ou um sal do mesmo, método para o tratamento de olho ressecado, e uso do agonista do receptor de p2y2, e ácido hialurônico ou um sal do mesmo."
BR112015014477A2 (pt) composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina
CL2012001366A1 (es) Compuestos derivados de carboxamida n-((2-morfolino-5-ariltiazol-4-il)metil), moduladores de receptores nicotinicos alfa 7; composicion farmaceutica; proceso para prepararla; combinacion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer, demencia, esquizofrenia, enfermedad de parkinson, entre otras.
PA8759501A1 (es) Formas cristalinas
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
PE20080053A1 (es) Composiciones oftalmicas de alcaftadina
PE20081751A1 (es) Composicion farmaceutica que comprende un antagonista muscarinico y antagonista beta-2 adrenorreceptor
PE20120648A1 (es) Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1
RU2012103538A (ru) Композиции и способы ингибирования пути jak
BR112013022094A2 (pt) composições e métodos para o tratamento não cirúrgico da ptose
BR112013026257A2 (pt) derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes

Legal Events

Date Code Title Description
FX Voluntary withdrawal